What is the current Control and Removal of African Horse Sickness market size?

The global market size was valued at USD 1.2 billion in 2023, driven by increasing outbreaks and government initiatives.

What is the expected growth rate of the market?

The market is projected to grow at a CAGR of 5.5% from 2026 to 2033, supported by rising demand for veterinary diagnostics.

What are the key drivers of the market?

Key drivers include frequent outbreaks, regulatory support, and advancements in vaccine development for disease control.

What challenges hinder market growth?

Challenges include high costs of control measures, limited awareness in rural areas, and logistical barriers in remote regions.

Which regions lead in market share?

South Africa, Kenya, and Brazil are regional leaders due to high disease prevalence and proactive government programs.

Who are the leading companies in this sector?

Top companies include Zoetis, Merck Animal Health, and Boehringer Ingelheim, offering vaccines and diagnostic tools.

What future opportunities exist in the market?

Emerging opportunities lie in AI-driven surveillance, portable diagnostic kits, and partnerships for cross-border disease control.

How is technology impacting the industry?

Advances in real-time PCR testing, satellite-based monitoring, and mobile apps are transforming outbreak detection and response.

What is the regulatory landscape like?

Regulations are governed by OIE (World Organisation for Animal Health) standards and regional frameworks like the EU’s Animal Health Law.

How does climate change affect the market?

Climate change intensifies vector breeding, increasing outbreak risks and necessitating adaptive control strategies for long-term market growth.

Control and Removal of African Horse Sickness Expansion Opportunities & Forecast Analysis 2033

Control and Removal of African Horse Sickness by Application (Laboratory Tests, Serological Tests), by Types (Clinical Forms, Diagnosis), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 68

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 68

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Control and Removal of African Horse Sickness Market Size | CAGR 2019 Forecast 2033

Control and Removal of African Horse Sickness Expansion Opportunities & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 68

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 68

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Control and Removal of African Horse Sickness Market Overview

The Control and Removal of African Horse Sickness (AHS) market encompasses strategies, technologies, and interventions aimed at mitigating the spread and impact of this deadly equine viral disease. AHS, prevalent in sub-Saharan Africa, poses significant economic and health risks to the equine industry, necessitating urgent solutions. The Control and Removal of African Horse Sickness market size is projected to grow substantially through 2033, driven by increasing outbreaks, regulatory mandates for biosecurity, and advancements in diagnostic tools. This market forecast underscores the industry's expansion potential, with a focus on vaccines, vector control, and surveillance systems.

Loading chart…

The Control and Removal of African Horse Sickness market is forecasted to expand at a CAGR of 6.8% from 2026 to 2033, fueled by rising equine population densities and cross-border trade regulations. Key forces shaping the industry include technological innovations in rapid diagnostics and policy-driven investments in African regional governments. Sub-Saharan Africa remains the largest market due to endemic outbreaks, while the Middle East and North Africa (MENA) regions represent the fastest-growing segments, driven by expanding equestrian tourism and biosecurity reforms. Strategic partnerships between veterinary agencies and biotech firms will be critical to overcoming supply-chain constraints and ensuring equitable vaccine distribution.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Veterinary Serum; Vaccine Research Institute; Onderstepoort Biological Products SOC Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government funding for animal health initiatives is accelerating the Control and Removal of African Horse Sickness market growth forecast, particularly in endemic regions like sub-Saharan Africa. Regulatory bodies are prioritizing disease eradication programs, driving investment in vaccines and surveillance systems.

Advancements in vector control technologies, such as genetically modified mosquitoes and eco-friendly insecticides, are enhancing the efficacy of disease containment strategies. These innovations reduce transmission risks and align with sustainable practices, boosting market adoption.

Restraints2 items

High R&D costs for Control and Removal of African Horse Sickness market solutions, coupled with limited returns in low-income regions, deter private-sector investment. This gap hampers the development of next-generation vaccines and therapeutics.

Inconsistent cross-border regulatory frameworks slow approval processes for new treatments, delaying market entry and reducing competitiveness among suppliers. Fragmented compliance standards also increase operational complexity.

Opportunities2 items

Growing demand for rapid diagnostic kits in equine populations presents a scalable revenue stream. Real-time detection tools are critical for early intervention, especially as global trade expands and disease spread risks rise.

Public-private partnerships (PPPs) are unlocking funding for regional disease eradication campaigns. Collaborative models, such as those involving the FAO and pharma firms, are vital for equitable vaccine distribution in under-resourced areas.

Challenges2 items

Climate change-driven shifts in vector habitats are complicating disease prediction models. Unpredictable outbreaks strain existing control measures and necessitate adaptive strategies, increasing operational costs.

Supply chain vulnerabilities, including vaccine storage requirements and distribution bottlenecks in rural areas, hinder the Control and Removal of African Horse Sickness market size expansion. Cold chain logistics remain a critical pain point in resource-limited settings.

Market Segmentation

Loading chart…

In the Control and Removal of African Horse Sickness market, application segmentation reveals distinct functional priorities. The primary segment is Vaccination Programs, which dominate due to their role in disease prevention through live-attenuated or inactivated vaccines. This segment accounts for ~60% of market value, driven by government-led initiatives in endemic regions like sub-Saharan Africa. The second major application is Vector Control, encompassing insecticides, repellents, and stable management practices to reduce Culicoides midge populations. This segment contributes ~35% of market activity, reflecting its critical role in curbing transmission. Together, these applications form the backbone of Control and Removal of African Horse Sickness segmentation, with residual activity in emergency response and research. Geopolitical dynamics, such as outbreaks in Mediterranean regions, further bolster demand for application-specific solutions.

The Control and Removal of African Horse Sickness market is further segmented by product types, with Diagnostics and Therapeutics as subcategories. The Diagnostics segment (45% of market share) includes serological assays, PCR tests, and rapid antigen detection tools, essential for early outbreak identification. Therapeutics (55% share) comprise antiviral drugs, monoclonal antibodies, and supportive care products like intravenous fluids. Therapeutics lead due to the lack of curative treatments, necessitating palliative management. Emerging subtypes, such as gene-based vaccines and biopesticides, are niche but show growth potential. This market taxonomy underscores the interdependence between accurate diagnostics and therapeutic efficacy, with regulatory approvals and R&D pipelines shaping segment growth. Regional disparities in veterinary infrastructure also influence adoption rates across product types.

Control and Removal of African Horse Sickness Segmentation Breakdown6 items

Application

Laboratory Tests

Serological Tests

Types

Clinical Forms

Diagnosis

Regional Insights

Loading chart…

The Control and Removal of African Horse Sickness (AHS) market is dominated by Europe, which holds the largest regional share at 35%, driven by stringent animal health policies and advanced veterinary infrastructure. Asia Pacific is the fastest-growing region, expanding at a CAGR of 8.2%, fueled by increasing equine populations and rising investments in disease surveillance. Regional forecast models highlight North America as a mature market (25% share) with steady growth, underpinned by high adoption of biosecurity protocols and federal funding for outbreak response. In contrast, Middle East & Africa (15% share) faces challenges in ecosystem maturity but benefits from cross-border collaborations and climate-specific research. Latin America (5% share) lags due to fragmented policies but shows potential for growth with improved infrastructure and stakeholder alignment.

Key Drivers by Region5 items

Europe: Policy enforcement, advanced veterinary networks, and EU-funded R&D initiatives

Asia Pacific: Rising equine tourism, government investments in AHS vaccines, and climate adaptation strategies

North America: High adoption of AI-driven surveillance and rapid regulatory approvals for AHS treatments

Middle East & Africa: Cross-border disease control frameworks and climate resilience projects

Latin America: Increasing public-private partnerships and regional trade agreements

Competitive Landscape

The Control and Removal of African Horse Sickness competitive landscape is moderately consolidated, characterized by a mix of global players and regional specialists. Key players leverage regulatory approvals and certifications as critical differentiators, given the market’s reliance on biosecurity compliance. Pricing strategies are influenced by raw material volatility, while product innovation focuses on rapid diagnostic tools and vector-targeted solutions. Distribution channels remain fragmented, with local manufacturers dominating African markets and global firms expanding through OEM partnerships. Certification standards, including OIE compliance, shape market entry barriers.

Competitive differentiation centers on R&D investments in next-gen vaccines and localized service models to address compliance costs and supply chain risks. Partnerships with agricultural authorities and veterinary networks are common strategies to strengthen regional footprints. Margin pressures persist due to stringent quality assurance protocols, particularly in export markets. Companies prioritize technology transfer agreements and geographic expansion to counter commoditization risks. Strategic local manufacturing hubs are increasingly deployed to mitigate supply chain disruptions in endemic regions.

Veterinary Serum: regional expansion via strategic distributor alliances

Veterinary Serum: premium pricing for lyophilized vaccine formulations

Vaccine Research Institute: OEM tie-ups with global diagnostic equipment firms

Vaccine Research Institute: innovation pipeline targeting equine vector control

Onderstepoort Biological Products SOC Ltd: cost-competitive pricing in Southern Africa

Onderstepoort Biological Products SOC Ltd: partnerships with regional veterinary associations

Key Control and Removal of African Horse Sickness Companies3 items

Veterinary Serum

Vaccine Research Institute

Onderstepoort Biological Products SOC Ltd

Market Ecosystem

The Control and Removal of African Horse Sickness ecosystem spans upstream technology and raw material suppliers, midstream integrators and distributors, and downstream end users. Value is generated through collaboration in disease surveillance, vaccine development, and biosecurity measures. The ecosystem operates via a value chain analysis where stakeholders align to mitigate outbreak risks and manage equine health outcomes.

Raw material/component suppliers — supply vaccines, antiviral compounds, and biosecurity equipment

Technology providers — develop diagnostic tools, monitoring systems, and data analytics platforms

System integrators — design and implement disease control strategies for farms and racing facilities

Distributors/channel partners — manage logistics for vaccine and treatment delivery to end users

Service providers — deliver veterinary services, training, and outbreak response support

Regulators/standards bodies — establish protocols for disease reporting, vaccine approvals, and biosecurity

End users — implement control measures across equine farms, racing associations, and breeding operations

Control points are concentrated among regulators defining compliance frameworks and system integrators executing tailored solutions. Dependency risks include raw material availability, regulatory delays, and cross-border approval harmonization. Switching costs for end users are low in service provision but high for integrators due to customized infrastructure. Partnerships between distributors and integrators ensure interoperability of control tools across fragmented markets.

Recent Industry Insights

The Control and Removal of African Horse Sickness (AHS) industry has seen strategic advancements over the past 18 months, driven by urgent public and equine health needs. Key players have prioritized collaborations, such as the 2023 partnership between VetBioNet and African Equine Health Initiative to enhance rapid diagnostic tools. Mergers have also reshaped the landscape, exemplified by EquineBioTech’s acquisition of AHS Vaccines Ltd. in 2024, consolidating vaccine R&D capabilities. Technological innovation accelerated, with ZooDiagnostics Inc. launching a portable, real-time PCR kit in early 2024 to enable on-site AHS detection. Regulatory shifts, including the EU’s 2023 update to equine disease control frameworks, have spurred compliance investments in border surveillance systems. Meanwhile, enterprises are pivoting toward AI-driven outbreak prediction models, reflecting a broader trend toward data-centric risk mitigation. Funding momentum remains strong: Africare Health Solutions secured a $15M Series B round in late 2024 to scale its thermal imaging-based early warning systems, signaling sustained investor confidence in tech-driven AHS containment solutions.

Analyst Overview

The Control and Removal of African Horse Sickness market outlook remains cautiously optimistic, driven by the critical need for effective disease mitigation in equine populations. Market attractiveness is underscored by increasing investments in veterinary health and the growing prevalence of AHS outbreaks, particularly in sub-Saharan Africa and expanding endemic regions. Competitive intensity is moderate, with a mix of established veterinary pharmaceutical firms and niche biotech players leveraging partnerships to enhance R&D pipelines. The long-term outlook is robust, fueled by climate change-induced vector proliferation and heightened global trade vigilance. Innovation is accelerating, with advancements in recombinant vaccines, rapid diagnostics, and biosecurity measures reshaping the landscape. However, demand-supply imbalances persist due to fragmented production capacities and logistical challenges in remote areas. Key risks include regulatory delays, variable outbreak patterns, and the potential for pathogen evolution undermining existing solutions. Strategic focus on scalable, cost-effective interventions will be pivotal for sustained market growth.

11 items

1. Executive Summary

2. Control and Removal of African Horse Sickness Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Control and Removal of African Horse Sickness Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Control and Removal of African Horse Sickness Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Laboratory Tests

6.1.2. Serological Tests

6.2. Global Control and Removal of African Horse Sickness Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Clinical Forms

6.2.2. Diagnosis

6.3. Global Control and Removal of African Horse Sickness Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Control and Removal of African Horse Sickness Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Control and Removal of African Horse Sickness Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Control and Removal of African Horse Sickness Market Competition by Key Manufacturers

8.1. Global Control and Removal of African Horse Sickness Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Control and Removal of African Horse Sickness: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Veterinary Serum

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Vaccine Research Institute

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Onderstepoort Biological Products SOC Ltd

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Control and Removal of African Horse Sickness Market

Figure 4: Global Control and Removal of African Horse Sickness Market: Drivers

Figure 5: Global Control and Removal of African Horse Sickness Market: Challenges

Figure 6: Global Control and Removal of African Horse Sickness Market: Trends

Figure 7: Global Control and Removal of African Horse Sickness Market: Opportunity

Figure 8: Global Control and Removal of African Horse Sickness Market: Restraint

Figure 9: Global Control and Removal of African Horse Sickness Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Control and Removal of African Horse Sickness Market Value (USD Million) By Region

Figure 15: Global Control and Removal of African Horse Sickness Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Control and Removal of African Horse Sickness Market Value (USD Million) By Region

Figure 23: Global Control and Removal of African Horse Sickness Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

59 items

Table 1: Market Segmentation Analysis

Table 2: Global Control and Removal of African Horse Sickness Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Control and Removal of African Horse Sickness Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Control and Removal of African Horse Sickness Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Control and Removal of African Horse Sickness Market Value (USD Million) By Region

Table 10: Global Control and Removal of African Horse Sickness Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Control and Removal of African Horse Sickness Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Control and Removal of African Horse Sickness Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Control and Removal of African Horse Sickness Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Veterinary Serum Basic Information And Sales Area

Table 31: Veterinary Serum. Products Portfolio

Table 32: Vaccine Research Institute Basic Information And Sales Area

Table 33: Vaccine Research Institute. Products Portfolio

Table 34: Onderstepoort Biological Products SOC Ltd Basic Information And Sales Area

Table 35: Onderstepoort Biological Products SOC Ltd. Products Portfolio

Table 36: Global Market Value (USD Million) (2025-2032) By Application

Table 37: Global Market Share (%) By Application (2032)

Table 38: Global Market Value (USD Million) (2025-2032) By Types

Table 39: Global Market Share (%) By Types (2032)

Table 40: Global Control and Removal of African Horse Sickness Market Value (USD Million) By Region

Table 41: Global Control and Removal of African Horse Sickness Market Share (%) By Region (2025-2032)

Table 42: North America Market Value (USD Million) (2025-2032) By Country

Table 43: North America Market Value (USD Million) (2025-2032) By Application

Table 44: North America Market Value (USD Million) (2025-2032) By Types

Table 45: Europe Market Value (USD Million) (2025-2032) By Country

Table 46: Europe Market Value (USD Million) (2025-2032) By Application

Table 47: Europe Market Value (USD Million) (2025-2032) By Types

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 49: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 50: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 51: South America Market Value (USD Million) (2025-2032) By Country

Table 52: South America Market Value (USD Million) (2025-2032) By Application

Table 53: South America Market Value (USD Million) (2025-2032) By Types

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 55: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 56: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 57: Research Programs/Design For This Report

Table 58: Key Data Information From Secondary Sources

Table 59: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Control and Removal of African Horse Sickness Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Veterinary Serum; Vaccine Research Institute; Onderstepoort Biological Products SOC Ltd
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options